PILRA and cerebral amyloid angiopathy: This could potentially indirectly point to a protective effect of PILRA on cSVD caused by cerebral amyloid angiopathy (CAA), as WM-PVS was recently proposed as a novel CAA biomarker40, and CAA is associated with a strongly increased risk of AD41.